Flowerkist Skin Care & Cosmetics, Inc. (FKST) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
4303 VINELAND RD., F2 ORLANDO, FL 32011 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8742 - Management Consulting Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2022 MRQ | 12/31/2021 | 7/31/2020 | 7/31/2019 | 7/31/2018 | 7/31/2017 | 7/31/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1 | ||||||||
| Cash and cash equivalents | 1 | ||||||||
| Total current assets: | 1 | ||||||||
| Noncurrent Assets | |||||||||
| TOTAL ASSETS: | 1 | ||||||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 0 | 232 | 232 | 232 | 232 | ||||
| Accounts payable | 0 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 232 | 232 | 232 | 232 | |||||
| Debt | 603 | 603 | 603 | 603 | 603 | ||||
| Due to related parties | 2 | 5 | |||||||
| Other undisclosed current liabilities | 232 | ||||||||
| Total current liabilities: | 2 | 840 | 835 | 835 | 835 | 835 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 43 | 43 | 43 | 43 | 43 | ||||
| Long-term debt, excluding current maturities | 43 | 43 | 43 | 43 | 43 | ||||
| Total noncurrent liabilities: | 43 | 43 | 43 | 43 | 43 | ||||
| Total liabilities: | 2 | 883 | 878 | 878 | 878 | 878 | |||
| Equity | |||||||||
| Equity, attributable to parent | (2) | (883) | (878) | (878) | (878) | (878) | |||
| Preferred stock | 1 | ||||||||
| Common stock | 0 | 130 | 130 | 130 | 130 | 130 | |||
| Additional paid in capital | 3,375 | 781 | 781 | 781 | 781 | 781 | |||
| Accumulated deficit | (3,378) | (1,794) | (1,789) | (1,789) | (1,789) | (1,789) | |||
| Total equity: | (2) | (883) | (878) | (878) | (878) | (878) | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2022 TTM | 12/31/2021 | 7/31/2020 | 7/31/2019 | 7/31/2018 | 7/31/2017 | 7/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 12 | |||||||
| Cost of revenue | (4) | |||||||
| Gross profit: | 8 | |||||||
| Operating expenses | (2) | (5) | (569) | |||||
| Operating loss: | (2) | (5) | (561) | |||||
| Nonoperating expense | (230) | |||||||
| Loss from continuing operations: | (2) | (5) | (791) | |||||
| Loss before gain (loss) on sale of properties: | (2) | (5) | (791) | |||||
| Net loss available to common stockholders, diluted: | (2) | (5) | (791) | |||||
Comprehensive Income ($ in thousands)
| 9/30/2022 TTM | 12/31/2021 | 7/31/2020 | 7/31/2019 | 7/31/2018 | 7/31/2017 | 7/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (2) | (5) | (791) | |||||
| Comprehensive loss, net of tax, attributable to parent: | (2) | (5) | (791) | |||||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.